TNF and sTNFR1/2 plasma levels in ALS patients
Cristina Cereda(University of Milan), Mauro Ceroni(University of Pavia), Paolo Bongioanni(Azienda Ospedaliera Universitaria Pisana), Chiara Baiocchi(University of Pavia), Stefania Guareschi(Thomas Jefferson University), Bruno Rossi(Universidade Federal de Santa Maria), Maria Rita Metelli(University of Pisa), Ilaria Sbalsi(University of Pavia), Maria Clara Cuccia(University of Pavia), Emanuela Cova(Fondazione Istituto Neurologico Nazionale Casimiro Mondino)
Cited by 92
Related Papers
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
|Nature Genetics|2021|567
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441